These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15765011)

  • 21. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein.
    Shimetani N; Shimetani K; Mori M
    Scand J Clin Lab Invest; 2004; 64(5):469-74. PubMed ID: 15276911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-guided antibiotic use in acute respiratory tract infections.
    Bollu M; Marte-Grau AC; Bobba RK
    Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP.
    Nyamande K; Lalloo UG
    Int J Tuberc Lung Dis; 2006 May; 10(5):510-5. PubMed ID: 16704032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
    Cunha BA
    Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biomarkers in Diagnosis, Treatment and Prognosis of Infectious Lung Diseases].
    Unnewehr M; Kolditz M; Windisch W; Schaaf B
    Pneumologie; 2018 May; 72(5):341-346. PubMed ID: 29046011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum procalcitonin in the diagnosis and management of intra-abdominal infections.
    Watkins RR; Lemonovich TL
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):197-205. PubMed ID: 22339193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assay for determination of the serum procalcitonin level: biochemical and clinical evaluation].
    Shimetani N; Ohba Y; Shimetani K; Mashiko T; Matsuyama N; Ohtani H; Morii M
    Rinsho Byori; 2001 Jan; 49(1):56-60. PubMed ID: 11215485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.
    Jereb M; Kotar T
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):170-4. PubMed ID: 16773483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Procalcitonin - marker of severe infection and sepsis].
    Didebulidze K; Manjavidze N; Ubiria I; Gogberashvili K
    Georgian Med News; 2007 Dec; (153):22-7. PubMed ID: 18250491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is procalcitonin measurement useful in managing respiratory tract infections?].
    Prins JM; van der Poll T
    Ned Tijdschr Geneeskd; 2016; 160():D957. PubMed ID: 27734780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin is a valuable prognostic marker in ARDS caused by community-acquired pneumonia.
    Tseng JS; Chan MC; Hsu JY; Kuo BI; Wu CL
    Respirology; 2008 Jun; 13(4):505-9. PubMed ID: 18422867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of procalcitonin and c-reactive protein levels: a diagnostic tool in lower respiratory tract infections.
    Ben Amar J; Zaibi H; Bouzid K; Azzabi S; Bacca MA; Dahari B; Aouina H
    Tunis Med; 2016 Mar; 94(3):176-80. PubMed ID: 27575499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers in lower respiratory tract infections.
    Blasi F; Stolz D; Piffer F
    Pulm Pharmacol Ther; 2010 Dec; 23(6):501-7. PubMed ID: 20434579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.
    Polzin A; Pletz M; Erbes R; Raffenberg M; Mauch H; Wagner S; Arndt G; Lode H
    Eur Respir J; 2003 Jun; 21(6):939-43. PubMed ID: 12797485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia.
    Schleicher GK; Herbert V; Brink A; Martin S; Maraj R; Galpin JS; Feldman C
    Eur Respir J; 2005 Apr; 25(4):688-92. PubMed ID: 15802344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.
    Kim HS; Won S; Lee EK; Chun YH; Yoon JS; Kim HH; Kim JT
    Pediatr Pulmonol; 2016 Jan; 51(1):42-8. PubMed ID: 25832310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
    Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
    J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procalcitonin-based guidelines and lower respiratory tract infections.
    Stijnis C; van Nieuwkoop C; van Dissel JT
    JAMA; 2010 Feb; 303(5):418-9; author reply 419-20. PubMed ID: 20124533
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
    Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
    J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.